Hirsuteine
CAS No. 35467-43-7
Hirsuteine( —— )
Catalog No. M24309 CAS No. 35467-43-7
Hirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 176 | In Stock |
|
10MG | 266 | In Stock |
|
25MG | 447 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHirsuteine
-
NoteResearch use only, not for human use.
-
Brief DescriptionHirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.
-
DescriptionHirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35467-43-7
-
Formula Weight366.45
-
Molecular FormulaC22H26N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (272.89 mM)
-
SMILESO=C(OC)/C([C@H]([C@H](CN1CC2)C=C)C[C@]1([H])C3=C2C(C=CC=C4)=C4N3)=C/OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Non-competitive antagonism by hirsuteine of nicotinic receptor-mediated dopamine release from rat pheochromocytoma cells.Jpn J Pharmacol. 1993 Apr;61(4):351-6.
molnova catalog
related products
-
3-CPMT
3-CPMT is a dopamine uptake inhibitor and a potent long-acting antihistaminic agent.
-
Pramipexole
A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
-
GSK 789472 hydrochlo...
GSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.